1236 Assessment of pharmacodynamic effect in a Phase I study of NPI-2358, an IV administered vascular disruptive agent, using dynamic contrast-enhanced MRI
2007 ◽
Vol 5
(4)
◽
pp. 135
◽
2009 ◽
Vol 7
(2)
◽
pp. 122
◽
2019 ◽
Vol 87
(9)
◽
pp. 3823-3832
2016 ◽
Vol 207
(5)
◽
pp. 1022-1030
◽